Package 51662-1358-1

Brand: amiodarone hydrochloride

Generic: amiodarone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51662-1358-1
Digits Only 5166213581
Product NDC 51662-1358
Description

1 VIAL, GLASS in 1 CARTON (51662-1358-1) / 18 mL in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2019-07-06
Brand amiodarone hydrochloride
Generic amiodarone hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "100d6df7-3400-6068-e063-6294a90a74f3", "openfda": {"unii": ["976728SY6Z"], "spl_set_id": ["8d088060-70b5-e796-e053-2995a90a0969"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (51662-1358-1)  / 18 mL in 1 VIAL, GLASS", "package_ndc": "51662-1358-1", "marketing_start_date": "20190706"}], "brand_name": "AMIODARONE HYDROCHLORIDE", "product_id": "51662-1358_100d6df7-3400-6068-e063-6294a90a74f3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antiarrhythmic [EPC]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51662-1358", "generic_name": "AMIODARONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AMIODARONE HYDROCHLORIDE", "active_ingredients": [{"name": "AMIODARONE HYDROCHLORIDE", "strength": "50 mg/mL"}], "application_number": "ANDA076217", "marketing_category": "ANDA", "marketing_start_date": "20190706", "listing_expiration_date": "20261231"}